{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:14:01Z","timestamp":1793186041769,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>A possible pathway behind gadolinium retention in brain is leakage of contrast agents from blood to cerebrospinal fluid and entry into brain along perivascular (glymphatic) pathways. The object of this study was to assess for signs of gadolinium retention in brain 4 weeks after intrathecal contrast enhanced MRI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We prospectively applied standardized T1 mapping of the brain before and 4 weeks after intrathecal administration of 0.5 mmol gadobutrol in patients under work-up of cerebrospinal fluid circulation disorders. Due to methodological limitations, a safety margin for percentage change in T1 time was set to 3%. Region-wise differences were assessed by pairwise comparison using <jats:italic>t<\/jats:italic>-tests and forest plots, and statistical significance was accepted at .05 level (two-tailed).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In a cohort of 76 participants (mean age 47.2 years <jats:bold>\u00b1<\/jats:bold> 17.9 [standard deviation], 47 women), T1 relaxation times remained unchanged in cerebral cortex and basal ganglia 4 weeks after intrathecal gadobutrol. T1 was reduced from 1082 <jats:bold>\u00b1<\/jats:bold> 46.7 ms to 1070.6 <jats:bold>\u00b1<\/jats:bold> 36.5 ms (0.98 <jats:bold>\u00b1<\/jats:bold>2.9%) (mean [standard deviation]) (<jats:italic>p<\/jats:italic>=0.001) in white matter, thus within the pre-defined 3% safety margin. The brain stem and cerebellum could not be assessed due to poor alignment of posterior fossa structures at scans from different time points.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Gadolinium retention was not detected in the cerebral hemispheres 4 weeks after an intrathecal dose of 0.5 mmol gadobutrol, implying that presence of contrast agents in cerebrospinal fluid is of minor importance for gadolinium retention in brain.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00234-023-03198-7","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T22:01:36Z","timestamp":1689976896000},"page":"1321-1331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prospective T1 mapping to assess gadolinium retention in brain after intrathecal gadobutrol"],"prefix":"10.1007","volume":"65","author":[{"given":"Geir","family":"Ringstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Magnus","family":"Valnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svein Are Sirirud","family":"Vatnehol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Are Hugo","family":"Pripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6881-9280","authenticated-orcid":false,"given":"Per Kristian","family":"Eide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"issue":"2","key":"3198_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1148\/radiol.2018181151","volume":"289","author":"RJ McDonald","year":"2018","unstructured":"McDonald RJ, Levine D, Weinreb J, Kanal E, Davenport MS, Ellis JH, Jacobs PM, Lenkinski RE, Maravilla KR, Prince MR, Rowley HA, Tweedle MF, Kressel HY (2018) Gadolinium retention: a research roadmap from the 2018 NIH\/ACR\/RSNA Workshop on gadolinium chelates. Radiology 289(2):517\u2013534. https:\/\/doi.org\/10.1148\/radiol.2018181151","journal-title":"Radiology"},{"issue":"2","key":"3198_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1148\/radiol.2019190461","volume":"294","author":"O Minaeva","year":"2020","unstructured":"Minaeva O, Hua N, Franz ES, Lupoli N, Mian AZ, Farris CW, Hildebrandt AM, Kiernan PT, Evers LE, Griffin AD, Liu X, Chancellor SE, Babcock KJ, Moncaster JA, Jara H, Alvarez VE, Huber BR, Guermazi A, Latour LL et al (2020) Nonhomogeneous gadolinium retention in the cerebral cortex after intravenous administration of gadolinium-based contrast agent in rats and humans. Radiology 294(2):377\u2013385. https:\/\/doi.org\/10.1148\/radiol.2019190461","journal-title":"Radiology"},{"issue":"3","key":"3198_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1148\/radiol.2021204320","volume":"300","author":"M Kobayashi","year":"2021","unstructured":"Kobayashi M, Levendovszky SR, Hippe DS, Hasegawa M, Murata N, Murata K, Marshall DA, Gonzalez-Cuyar LF, Maravilla KR (2021) Comparison of human tissue gadolinium retention and elimination between gadoteridol and gadobenate. Radiology 300(3):559\u2013569. https:\/\/doi.org\/10.1148\/radiol.2021204320","journal-title":"Radiology"},{"issue":"1","key":"3198_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1148\/radiol.2015142690","volume":"276","author":"T Kanda","year":"2015","unstructured":"Kanda T, Fukusato T, Matsuda M, Toyoda K, Oba H, Kotoku J, Haruyama T, Kitajima K, Furui S (2015) Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 276(1):228\u2013232. https:\/\/doi.org\/10.1148\/radiol.2015142690","journal-title":"Radiology"},{"issue":"7","key":"3198_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/RLI.0000000000000252","volume":"51","author":"N Murata","year":"2016","unstructured":"Murata N, Gonzalez-Cuyar LF, Murata K, Fligner C, Dills R, Hippe D, Maravilla KR (2016) Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function. Investig Radiol 51(7):447\u2013453. https:\/\/doi.org\/10.1097\/RLI.0000000000000252","journal-title":"Investig Radiol"},{"issue":"2","key":"3198_CR6","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1148\/radiol.2017161595","volume":"285","author":"RJ McDonald","year":"2017","unstructured":"McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Paolini MA, Murray DL, Williamson EE, Eckel LJ (2017) Gadolinium deposition in human brain tissues after contrast-enhanced MR imaging in adult patients without intracranial abnormalities. Radiology 285(2):546\u2013554. https:\/\/doi.org\/10.1148\/radiol.2017161595","journal-title":"Radiology"},{"issue":"7","key":"3198_CR7","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1007\/s00330-016-4654-2","volume":"27","author":"G Jost","year":"2017","unstructured":"Jost G, Frenzel T, Lohrke J, Lenhard DC, Naganawa S, Pietsch H (2017) Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue. Eur Radiol 27(7):2877\u20132885. https:\/\/doi.org\/10.1007\/s00330-016-4654-2","journal-title":"Eur Radiol"},{"issue":"9","key":"3198_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/RLI.0000000000000473","volume":"53","author":"T Taoka","year":"2018","unstructured":"Taoka T, Jost G, Frenzel T, Naganawa S, Pietsch H (2018) Impact of the glymphatic system on the kinetic and distribution of gadodiamide in the rat brain: observations by dynamic MRI and effect of circadian rhythm on tissue gadolinium concentrations. Investig Radiol 53(9):529\u2013534. https:\/\/doi.org\/10.1097\/RLI.0000000000000473","journal-title":"Investig Radiol"},{"key":"3198_CR9","doi-asserted-by":"publisher","first-page":"102456","DOI":"10.1016\/j.nicl.2020.102456","volume":"28","author":"WM Freeze","year":"2020","unstructured":"Freeze WM, van der Thiel M, de Bresser J, Klijn CJM, van Etten ES, Jansen JFA, van der Weerd L, Jacobs HIL, Backes WH, van Veluw SJ (2020) CSF enhancement on post-contrast fluid-attenuated inversion recovery images; a systematic review. Neuroimage Clin 28:102456. https:\/\/doi.org\/10.1016\/j.nicl.2020.102456","journal-title":"Neuroimage Clin"},{"issue":"3","key":"3198_CR10","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1148\/radiol.2018171829","volume":"288","author":"F Berger","year":"2018","unstructured":"Berger F, Kubik-Huch RA, Niemann T, Schmid HR, Poetzsch M, Froehlich JM, Beer JH, Thali MJ, Kraemer T (2018) Gadolinium distribution in cerebrospinal fluid after administration of a gadolinium-based MR contrast agent in humans. Radiology 288(3):703\u2013709. https:\/\/doi.org\/10.1148\/radiol.2018171829","journal-title":"Radiology"},{"issue":"2","key":"3198_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1148\/radiol.2018171105","volume":"288","author":"AK Nehra","year":"2018","unstructured":"Nehra AK, McDonald RJ, Bluhm AM, Gunderson TM, Murray DL, Jannetto PJ, Kallmes DF, Eckel LJ, McDonald JS (2018) Accumulation of gadolinium in human cerebrospinal fluid after gadobutrol-enhanced MR imaging: a prospective observational cohort study. Radiology 288(2):416\u2013423. https:\/\/doi.org\/10.1148\/radiol.2018171105","journal-title":"Radiology"},{"issue":"4","key":"3198_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/RLI.0000000000000533","volume":"54","author":"K Deike-Hofmann","year":"2019","unstructured":"Deike-Hofmann K, Reuter J, Haase R, Paech D, Gnirs R, Bickelhaupt S, Forsting M, Heussel CP, Schlemmer HP, Radbruch A (2019) Glymphatic pathway of gadolinium-based contrast agents through the brain: overlooked and misinterpreted. Investig Radiol 54(4):229\u2013237. https:\/\/doi.org\/10.1097\/RLI.0000000000000533","journal-title":"Investig Radiol"},{"issue":"147","key":"3198_CR13","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, Nagelhus EA, Nedergaard M (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Trans Med 4(147):147ra111. https:\/\/doi.org\/10.1126\/scitranslmed.3003748","journal-title":"Sci Trans Med"},{"key":"3198_CR14","doi-asserted-by":"publisher","unstructured":"Ringstad G, Valnes LM, Dale AM, Pripp AH, Vatnehol SS, Emblem KE, Mardal KA, Eide PK (2018) Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI. Insight 3(13). https:\/\/doi.org\/10.1172\/jci.insight.121537","DOI":"10.1172\/jci.insight.121537"},{"issue":"4","key":"3198_CR15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3174\/ajnr.A5931","volume":"40","author":"R Watts","year":"2019","unstructured":"Watts R, Steinklein JM, Waldman L, Zhou X, Filippi CG (2019) Measuring glymphatic flow in man using quantitative contrast-enhanced MRI. AJNR Am J Neuroradiol 40(4):648\u2013651. https:\/\/doi.org\/10.3174\/ajnr.A5931","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"3198_CR16","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1007\/s00330-016-4269-7","volume":"26","author":"J Ramalho","year":"2016","unstructured":"Ramalho J, Semelka RC, AlObaidy M, Ramalho M, Nunes RH, Castillo M (2016) Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide. Eur Radiol 26(11):4080\u20134088. https:\/\/doi.org\/10.1007\/s00330-016-4269-7","journal-title":"Eur Radiol"},{"issue":"1","key":"3198_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1148\/radiol.2016160674","volume":"283","author":"H Kuno","year":"2017","unstructured":"Kuno H, Jara H, Buch K, Qureshi MM, Chapman MN, Sakai O (2017) Global and regional brain assessment with quantitative MR imaging in patients with prior exposure to linear gadolinium-based contrast agents. Radiology 283(1):195\u2013204. https:\/\/doi.org\/10.1148\/radiol.2016160674","journal-title":"Radiology"},{"issue":"1","key":"3198_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1148\/radiol.2017162852","volume":"287","author":"KM Kang","year":"2018","unstructured":"Kang KM, Choi SH, Hwang M, Yun TJ, Kim JH, Sohn CH (2018) T1 shortening in the globus pallidus after multiple administrations of gadobutrol: assessment with a multidynamic multiecho sequence. Radiology 287(1):258\u2013266. https:\/\/doi.org\/10.1148\/radiol.2017162852","journal-title":"Radiology"},{"issue":"12","key":"3198_CR19","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1007\/s00330-016-4245-2","volume":"26","author":"E Tedeschi","year":"2016","unstructured":"Tedeschi E, Palma G, Canna A, Cocozza S, Russo C, Borrelli P, Lanzillo R, Angelini V, Postiglione E, Morra VB, Salvatore M, Brunetti A, Quarantelli M (2016) In vivo dentate nucleus MRI relaxometry correlates with previous administration of gadolinium-based contrast agents. Eur Radiol 26(12):4577\u20134584. https:\/\/doi.org\/10.1007\/s00330-016-4245-2","journal-title":"Eur Radiol"},{"issue":"8","key":"3198_CR20","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3174\/ajnr.A6112","volume":"40","author":"Y Forslin","year":"2019","unstructured":"Forslin Y, Martola J, Bergendal A, Fredrikson S, Wiberg MK, Granberg T (2019) Gadolinium retention in the brain: an MRI relaxometry study of linear and macrocyclic gadolinium-based contrast agents in multiple sclerosis. AJNR Am J Neuroradiol 40(8):1265\u20131273. https:\/\/doi.org\/10.3174\/ajnr.A6112","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"3198_CR21","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/mrm.21836","volume":"61","author":"W Shin","year":"2009","unstructured":"Shin W, Gu H, Yang Y (2009) Fast high-resolution T1 mapping using inversion-recovery Look-Locker echo-planar imaging at steady state: optimization for accuracy and reliability. Magn Reson Med 61(4):899\u2013906. https:\/\/doi.org\/10.1002\/mrm.21836","journal-title":"Magn Reson Med"},{"key":"3198_CR22","first-page":"105","volume-title":"Berlin, Heidelberg","author":"JJ Mor\u00e9","year":"1978","unstructured":"Mor\u00e9 JJ (1978) The Levenberg-Marquardt algorithm: implementation and theory. In: Berlin, Heidelberg. Numerical Analysis. Springer, Berlin Heidelberg, pp 105\u2013116"},{"issue":"1","key":"3198_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mrm.20110","volume":"52","author":"DR Messroghli","year":"2004","unstructured":"Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP (2004) Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 52(1):141\u2013146. https:\/\/doi.org\/10.1002\/mrm.20110","journal-title":"Magn Reson Med"},{"issue":"2","key":"3198_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1148\/radiol.2019182360","volume":"292","author":"G Korzdorfer","year":"2019","unstructured":"Korzdorfer G, Kirsch R, Liu K, Pfeuffer J, Hensel B, Jiang Y, Ma D, Gratz M, Bar P, Bogner W, Springer E, Lima Cardoso P, Umutlu L, Trattnig S, Griswold M, Gulani V, Nittka M (2019) Reproducibility and repeatability of MR fingerprinting relaxometry in the human brain. Radiology 292(2):429\u2013437. https:\/\/doi.org\/10.1148\/radiol.2019182360","journal-title":"Radiology"},{"issue":"3","key":"3198_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1148\/radiol.2021203784","volume":"300","author":"S Lee","year":"2021","unstructured":"Lee S, Yoo RE, Choi SH, Oh SH, Ji S, Lee J, Huh KY, Lee JY, Hwang I, Kang KM, Yun TJ, Kim JH, Sohn CH (2021) Contrast-enhanced MRI T1 mapping for quantitative evaluation of putative dynamic glymphatic activity in the human brain in sleep-wake states. Radiology 300(3):661\u2013668. https:\/\/doi.org\/10.1148\/radiol.2021203784","journal-title":"Radiology"},{"issue":"1","key":"3198_CR26","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1148\/radiol.2020202819","volume":"297","author":"E Kanal","year":"2020","unstructured":"Kanal E (2020) A reality check on intrathecal gadolinium-based contrast agents. Radiology 297(1):84\u201386. https:\/\/doi.org\/10.1148\/radiol.2020202819","journal-title":"Radiology"},{"issue":"4","key":"3198_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/RLI.0000000000000327","volume":"52","author":"AY Oner","year":"2017","unstructured":"Oner AY, Barutcu B, Aykol S, Tali ET (2017) Intrathecal contrast-enhanced magnetic resonance imaging-related brain signal changes: residual gadolinium deposition? Investig Radiol 52(4):195\u2013197. https:\/\/doi.org\/10.1097\/RLI.0000000000000327","journal-title":"Investig Radiol"},{"issue":"9","key":"3198_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/RLI.0000000000000472","volume":"53","author":"K Ozturk","year":"2018","unstructured":"Ozturk K, Nas OF, Soylu E, Hakyemez B (2018) Signal changes in the dentate nucleus and globus pallidus on unenhanced T1-weighted magnetic resonance images after intrathecal administration of macrocyclic gadolinium contrast agent. Investig Radiol 53(9):535\u2013540. https:\/\/doi.org\/10.1097\/RLI.0000000000000472","journal-title":"Investig Radiol"},{"key":"3198_CR29","doi-asserted-by":"publisher","unstructured":"Green C, Jost G, Frenzel T, Boyken J, Schwenke C, Pietsch H (2022) The effect of gadolinium-based contrast agents on longitudinal changes of magnetic resonance imaging signal intensities and relaxation times in the aging rat brain. Investig Radiol. https:\/\/doi.org\/10.1097\/RLI.0000000000000857","DOI":"10.1097\/RLI.0000000000000857"},{"issue":"2","key":"3198_CR30","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/mrm.25135","volume":"73","author":"N Stikov","year":"2015","unstructured":"Stikov N, Boudreau M, Levesque IR, Tardif CL, Barral JK, Pike GB (2015) On the accuracy of T1 mapping: searching for common ground. Magn Reson Med 73(2):514\u2013522. https:\/\/doi.org\/10.1002\/mrm.25135","journal-title":"Magn Reson Med"},{"issue":"1","key":"3198_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/mrm.20552","volume":"54","author":"R Deichmann","year":"2005","unstructured":"Deichmann R (2005) Fast high-resolution T1 mapping of the human brain. Magn Reson Med 54(1):20\u201327. https:\/\/doi.org\/10.1002\/mrm.20552","journal-title":"Magn Reson Med"},{"issue":"1","key":"3198_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1148\/radiol.2020191373","volume":"297","author":"M Patel","year":"2020","unstructured":"Patel M, Atyani A, Salameh JP, McInnes M, Chakraborty S (2020) Safety of intrathecal administration of gadolinium-based contrast agents: a systematic review and meta-analysis. Radiology 297(1):75\u201383. https:\/\/doi.org\/10.1148\/radiol.2020191373","journal-title":"Radiology"},{"issue":"8","key":"3198_CR33","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3174\/ajnr.A6136","volume":"40","author":"CS Edeklev","year":"2019","unstructured":"Edeklev CS, Halvorsen M, Lovland G, Vatnehol SAS, Gjertsen O, Nedregaard B, Sletteberg R, Ringstad G, Eide PK (2019) Intrathecal use of gadobutrol for glymphatic MR imaging: prospective safety study of 100 patients. AJNR Am J Neuroradiol 40(8):1257\u20131264. https:\/\/doi.org\/10.3174\/ajnr.A6136","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"3198_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00234-020-02519-4","volume":"63","author":"M Halvorsen","year":"2021","unstructured":"Halvorsen M, Edeklev CS, Fraser-Green J, Lovland G, Vatnehol SAS, Gjertsen O, Nedregaard B, Sletteberg R, Ringstad G, Eide PK (2021) Off-label intrathecal use of gadobutrol: safety study and comparison of administration protocols. Neuroradiology 63(1):51\u201361. https:\/\/doi.org\/10.1007\/s00234-020-02519-4","journal-title":"Neuroradiology"},{"key":"3198_CR35","unstructured":"Bayer (2021) Gadovist product monograph. https:\/\/www.bayer.com\/sites\/default\/files\/2020-11\/gadovist-pm-en_0.pdf. Accessed 30 Sept 2021"},{"key":"3198_CR36","doi-asserted-by":"publisher","unstructured":"Eide PK, Mariussen E, Uggerud H, Pripp AH, Lashkarivand A, Hassel B, Christensen H, Hovd MH, Ringstad G (2021) Clinical application of intrathecal gadobutrol for assessment of cerebrospinal fluid tracer clearance to blood. JCI. Insight 6(9). https:\/\/doi.org\/10.1172\/jci.insight.147063","DOI":"10.1172\/jci.insight.147063"},{"issue":"6","key":"3198_CR37","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1002\/mrm.28389","volume":"84","author":"D Cao","year":"2020","unstructured":"Cao D, Kang N, Pillai JJ, Miao X, Paez A, Xu X, Xu J, Li X, Qin Q, Van Zijl PCM, Barker P, Hua J (2020) Fast whole brain MR imaging of dynamic susceptibility contrast changes in the cerebrospinal fluid (cDSC MRI). Magn Reson Med 84(6):3256\u20133270. https:\/\/doi.org\/10.1002\/mrm.28389","journal-title":"Magn Reson Med"},{"issue":"3","key":"3198_CR38","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/mrm.10567","volume":"50","author":"MJ van Osch","year":"2003","unstructured":"van Osch MJ, Vonken EJ, Wu O, Viergever MA, van der Grond J, Bakker CJ (2003) Model of the human vasculature for studying the influence of contrast injection speed on cerebral perfusion MRI. Magn Reson Med 50(3):614\u2013622. https:\/\/doi.org\/10.1002\/mrm.10567","journal-title":"Magn Reson Med"},{"issue":"5","key":"3198_CR39","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/mrm.21066","volume":"56","author":"GJ Parker","year":"2006","unstructured":"Parker GJ, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, Buckley DL, Jackson A, Watson Y, Davies K, Jayson GC (2006) Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 56(5):993\u20131000. https:\/\/doi.org\/10.1002\/mrm.21066","journal-title":"Magn Reson Med"},{"issue":"2","key":"3198_CR40","first-page":"167","volume":"16","author":"HJ Weinmann","year":"1984","unstructured":"Weinmann HJ, Laniado M, Mutzel W (1984) Pharmacokinetics of GdDTPA\/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 16(2):167\u2013172","journal-title":"Physiol Chem Phys Med NMR"},{"issue":"2","key":"3198_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/mrm.1910170208","volume":"17","author":"PS Tofts","year":"1991","unstructured":"Tofts PS, Kermode AG (1991) Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1 Fundamental concepts. Magn Reson Med 17(2):357\u2013367. https:\/\/doi.org\/10.1002\/mrm.1910170208","journal-title":"Magn Reson Med"},{"issue":"2","key":"3198_CR42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, Harrington MG, Chui HC, Law M, Zlokovic BV (2015) Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85(2):296\u2013302. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.032","journal-title":"Neuron"},{"issue":"1","key":"3198_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","volume":"74","author":"JM Starr","year":"2003","unstructured":"Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I (2003) Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry 74(1):70\u201376. https:\/\/doi.org\/10.1136\/jnnp.74.1.70","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"3198_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.pscychresns.2008.04.003","volume":"171","author":"JM Starr","year":"2009","unstructured":"Starr JM, Farrall AJ, Armitage P, McGurn B, Wardlaw J (2009) Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study. Psychiatry Res 171(3):232\u2013241. https:\/\/doi.org\/10.1016\/j.pscychresns.2008.04.003","journal-title":"Psychiatry Res"},{"issue":"2","key":"3198_CR45","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1148\/radiol.2016152244","volume":"281","author":"HJ van de Haar","year":"2016","unstructured":"van de Haar HJ, Burgmans S, Jansen JF, van Osch MJ, van Buchem MA, Muller M, Hofman PA, Verhey FR, Backes WH (2016) Blood-brain barrier leakage in patients with early Alzheimer disease. Radiology 281(2):527\u2013535. https:\/\/doi.org\/10.1148\/radiol.2016152244","journal-title":"Radiology"},{"issue":"8","key":"3198_CR46","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1161\/STROKEAHA.110.611731","volume":"42","author":"S Taheri","year":"2011","unstructured":"Taheri S, Gasparovic C, Huisa BN, Adair JC, Edmonds E, Prestopnik J, Grossetete M, Shah NJ, Wills J, Qualls C, Rosenberg GA (2011) Blood-brain barrier permeability abnormalities in vascular cognitive impairment. Stroke 42(8):2158\u20132163. https:\/\/doi.org\/10.1161\/STROKEAHA.110.611731","journal-title":"Stroke"},{"issue":"3","key":"3198_CR47","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1148\/radiol.2017162857","volume":"285","author":"E Gianolio","year":"2017","unstructured":"Gianolio E, Bardini P, Arena F, Stefania R, Di Gregorio E, Iani R, Aime S (2017) Gadolinium retention in the rat brain: assessment of the amounts of insoluble gadolinium-containing species and intact gadolinium complexes after repeated administration of gadolinium-based contrast agents. Radiology 285(3):839\u2013849. https:\/\/doi.org\/10.1148\/radiol.2017162857","journal-title":"Radiology"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-023-03198-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-023-03198-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-023-03198-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T02:02:57Z","timestamp":1692064977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00234-023-03198-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["3198"],"URL":"https:\/\/doi.org\/10.1007\/s00234-023-03198-7","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"10 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}